Additionally, pharmacokinetic differences were predicted in subjects based on factors such as age, body weight, sex, race, ethnicity, and injection site, with most GLP-1 RAs and a dual GLP-1/GIP RA exhibiting only minor variations
GLP-1s, which help people with diabetes by stimulating insulin secretion and curbing appetite, have grown into one of the biggest drug classes because of their potent effects on blood sugar and body weight
It is likely safe to take year round
Biochem Pharmacol 229:116471 Kelly CA, Sipos JA (2024) Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists
This can have important physiologic effects on metabolism and overall health